Brief: Antengene Says NMPA Granted Marketing Approval For Selinexor (Atg-010) In China
17/12/2021 24:22
Dec 17 (Reuters) - Antengene Corporation Ltd 6996.HK :
* ANTENGENE CORP - NMPA GRANTED MARKETING APPROVAL FOR
SELINEXOR
(ATG-010) IN CHINA
Source text for Eikon: ID:nHKS59hJzv
Further company coverage: 6996.HK
(Reuters.briefs@thomsonreuters.com)
Recent news on Antengene
See all newsBiotech firm Antengene's H1 revenue jumps on licensing deals
Brief: Antengene Corp Expects HY Profit Of RMB195 MLN-RMB238 MLN
Brief: Antengene Corp Receives Initial $60 Million Upfront Payment From UCB
Brief: Antengene Corp Intends To Repurchase Up To 67.92 Million Shares
Brief: Antengene Corp Enters Exclusive License Agreement With K2 Therapeutics For Atg-106